XML 29 R13.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings per Share | 3 Months Ended
--- | ---
May 02, 2020
Earnings Per Share [Abstract] |
Earnings per Share | 5. Earnings per Share The following is a reconciliation between basic and diluted weighted average shares outstanding:
|  | 13 Weeks Ended |
|  | May 2, |  |  | May 4, |
(In thousands) |  | 2020 |  |  | 2019 |
Weighted average common shares outstanding: |  |  |  |  |  |  |  |
Basic number of common shares outstanding |  |  | 166,781 |  |  |  | 172,598 |
Dilutive effect of stock options and non-vested restricted stock* |  |  | — |  |  |  | 1,475 |
Diluted number of common shares outstanding |  |  | 166,781 |  |  |  | 174,073 |
Anti-Dilutive Shares* |  |  | 3,040 |  |  |  | 171 |
*For the quarter ended May 2, 2020, there were 0.7 million potentially dilutive equity awards that were excluded from diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. The Company has the right to settle its convertible notes in any combination of cash and shares of common stock. However, the Company intends to settle the original principal portion of the notes in cash and any conversion value above the principal in stock. Because of this repayment policy, only the conversion spread portion of the amount owed is reflected as dilutive in our weighted average diluted shares outstanding. The Company uses the average of the closing prices of its common stock (NYSE: AEO) as reported on the New York Stock Exchange for the most recent quarter to calculate the conversion spread. For the period of issuance of the convertible notes through May 2, 2020, the average closing price of our stock was below the conversion price per share of $8.75, and, therefore, the convertible notes did not have a dilutive effect. These convertible notes could have a potential dilutive effect in future periods. Dilutive and anti-dilutive shares relate to share based compensation. Refer to Note 8 and 9 to the Consolidated Financial Statements for additional information regarding our convertible notes and share-based compensation, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration